Last Updated: 17/09/2024
The anti-infectivity efficacy and pharmacokinetics of WHO-recommended single low dose primaquine in children with acute Plasmodium falciparum
Objectives
To assess the effectiveness of a single low dose of pediatric primaquine in children with acute uncomplicated falciparum malaria, adapting the WHO-recommended adult dose (0.25 mg/kg).
Principal Institution
Principal Investigators / Focal Persons
Study Design
-
Study design: Randomized open-label study
-
Primary study design: Interventional
-
Secondary study design: Randomised controlled trial
-
Trial setting: Hospitals
- Trial type: Treatment
External reference
Thematic Categories
Date
Sep 2020 — Dec 2024
Total Project Funding
$4.16M
Funding Details
European and Developing Countries Clinical Trials Partnership (EDCTP), The Netherlands
SCHEME: Paediatric drug formulations for poverty-related diseases – 2019
EUR 3.49M
Project Site
Related Resources
